Reported Reactions

Adverse event reports that FDA received

  • Search
  • Watch list

Iodine adverse event reports that FDA received

Name type
Generic name
Also reported as
Iodine Solution, Iodine Nos

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on . The data have the reports that FDA received through .

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on .

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Drug reports received through . Device reports have a separate cutoff, 30 Sep 2026. Why a report count is not a rate.

Reports on file

From February 2004 to June 2026, FDA received 2,051 adverse event reports that name Iodine. In these reports the drug is a suspect or interacting product.

In the same period, 1,572 further reports name it only as a concomitant medicine. The counts on this page do not include these reports.

FDA received 162 reports in the 12 months to June 2026 and 233 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Of the 1,332,454 drug reports that FDA received in the 12 months to June 2026, 162 (under 0.1%) name Iodine. Reports from consumers or other non-health professionals were 19.5% of the reports that name Iodine and 45.8% of all drug reports.

The number of people who use the product is not in the data. A count is not a rate. A count of reports is not a count of events or of patients, because one event can have more than one report.

There are many instances of duplicative reports and some reports do not contain all the necessary information.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Suspect product

FDA records each drug in a report as suspect, concomitant or interacting. This page counts the reports in which Iodine is suspect or interacting. FDA says:

Any number of the drugs may be marked as suspect if thought to be responsible for one or more of the reactions, but that information is not validated.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Data version

openFDA FAERS release of 29 Oct 2026. Reports received through 30 Jun 2026.

Since the last update

FDA says:

Many factors can influence whether or not an event will be reported, such as the time a product has been marketed and publicity about an event.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

The information in these reports cannot be used to estimate the incidence (occurrence rates) of the events reported.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

The latest update of the FDA data, recorded on , changed no count of this page.

  • In April to June 2026, FDA received 42 reports that name Iodine.
  • In January to March 2026, FDA received 32.
  • In April to June 2025, FDA received 40.

April to June 2026 is the latest closed quarter in the data. A closed quarter is a quarter for which the FDA files have most of the reports.

All updatesFeed of updates (RSS)

Reaction lookup

These are the reaction terms that the reports record, with the number of reports for each term. Type a term or a plain word to find its count.

What this list leaves out

The table lists the 381 reaction terms that 5 or more reports record. A term with fewer than 5 reports is not in the table.

The site keeps reaction terms for 2,003 of the 2,051 reports (97.7%).

The reports of the other years are not in the counts.

So a count in the table can be lower than the count of FDA.

The table shows the first 50 of 381 terms.

Reaction terms in the reports that name Iodine, most reports first
Reaction term (MedDRA) and plain meaningReportsShare of the 2,051 reports
Drug hypersensitivityan allergic-type reaction (the term names a medicine)1,07952.6%
Nauseafeeling sick33816.5%
Dyspnoeashortness of breath31015.1%
Fatiguetiredness28814%
Diarrhoealoose or frequent stools26813.1%
Arthralgiajoint pain26112.7%
Headachehead pain24311.8%
Pruritusitching24311.8%
Vomitingbeing sick22911.2%
Off label useused for a purpose or in a way not on the label21710.6%
Dizzinesslight-headedness or unsteadiness21610.5%
Pyrexiafever21410.4%
Falla fall21010.2%
Malaisegeneral feeling of being unwell20810.1%
Drug ineffectivethe medicine did not work as expected20710.1%
Abdominal painstomach or belly pain20510%
Abdominal pain upperupper stomach pain2019.8%
Decreased appetitereduced appetite1949.5%
Rashskin rash1808.8%
Astheniaweakness or lack of energy1778.6%
Insomniadifficulty sleeping1768.6%
Painpain, site not specified1738.4%
Tachycardiafast heart rate1627.9%
Psoriatic arthropathy1557.6%
Chillschills or shivering1547.5%
Syncopefainting1537.5%
Haemorrhagic stroke1527.4%
Systemic lupus erythematosuslupus, an autoimmune disease1527.4%
Type 2 diabetes mellitustype 2 diabetes1477.2%
Rheumatoid arthritisrheumatoid arthritis, an inflammatory joint disease1467.1%
Swelling1467.1%
Product use in unapproved indicationused for a purpose not on the label1437%
Blindnessloss of sight1406.8%
Coma1406.8%
Cough1406.8%
Eye pain1396.8%
Ocular discomfort1396.8%
Synovitis1396.8%
Amaurosis fugax1386.7%
Haematemesis1386.7%
Urticariahives1366.6%
Head discomfortdiscomfort in the head1356.6%
Altered state of consciousness1336.5%
Infusion related reactiona reaction during or soon after an infusion1316.4%
Ascitesfluid in the abdomen1306.3%
Blood pressure increaseda raised blood pressure reading1306.3%
Cardio-respiratory arrestthe heart and breathing stopped1306.3%
Pemphigus1306.3%
Haematuriablood in the urine1296.3%
Sepsisa severe body-wide response to infection1296.3%

Download all 381 terms of Iodine (CSV)

The counts add to more than 2,051 reports, because one report can record more than one term. FDA says:

No individual drug is connected to any individual reaction. When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

The CSV file has the same rows and the same limits. Its last row is a note that says so.

MedDRA term

The person who codes a report selects the preferred term that agrees best with the description of the reporter. The words under a term are the plain meaning that this site gives.

Not the label

The FDA-approved label of a product lists its adverse reactions. See the official pages at the end of this page.

Outcomes by year

The table gives the outcomes that the reporters gave, in the terms of FDA.

Outcomes in the reports that name Iodine, by the year of the openFDA file that holds the report

The table continues to the right.

Year of the openFDA fileReportsSeriousDeathLife-threateningHospitalization (initial or prolonged)Disability or Permanent DamageCongenital Anomaly/Birth DefectOther Serious (Important Medical Events)Not serious
2004171418110023
2005660140130
2006330220030
2007750020042
2008660011050
2009640010042
2010770122040
2011981140041
201223601200617
20138418037101266
2014921001300882
20151091302300996
2016190325351027158
2017123191091013104
2018122361116082486
20192644510130635219
2020112331122102679
202197660330106031
202273529215114221
2023947021422006024
20241951831144968292016012
20252362231571341471325621513
2026176172103859480551634

An outcome in a report is not proof that the drug was the cause. The reporter gives the outcome, and FDA does not verify it. FDA says:

The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

The six headings with the names of FDA are the outcome terms of FDA. A report can have more than one outcome. The columns Serious and Not serious are the two values of the openFDA field serious. For the value serious, openFDA gives this description:

The adverse event resulted in death, a life threatening condition, hospitalization, disability, congenital anomaly, or other serious condition

Source: openFDA, Drug adverse event fields (YAML reference). The site read the page on .

The year is the year of the openFDA file that holds the latest version of the report. It is not always the year in which FDA first received the report. The chart of the next section uses the year of first receipt. The latest year is not complete.

Reports by year and month

Reports that name Iodine, by the year in which FDA received them
0250500200420082012201620202024

The column of 2026 has an outline, because the year is not complete. It has the reports that FDA received through June 2026 only.

Show the figures of the chart as a table
Reports that name Iodine, by the year in which FDA received them
YearReports
200416
20056
20063
20078
20086
20094
201010
201111
201230
201393
2014108
2015124
2016207
2017134
2018156
2019216
2020106
202187
202289
2023115
2024253
2025195
202674
Reports that name Iodine, by month, five years to June 2026
0255020222023202420252026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Why a count moves

A count moves for many reasons. The guide gives FDA's words about them.

Patients and reporters

Age of the patient in the reports that name Iodine
AgeReportsShareShare as a bar
Under 270.3%
2 to 1120.1%
12 to 1760.3%
18 to 4431415.3%
45 to 6446222.5%
65 to 7429814.5%
75 and over24411.9%
Age not given71835%
Sex of the patient in the reports that name Iodine
SexReportsShareShare as a bar
Female1,30963.8%
Male36117.6%
Unknown or not given38118.6%
Type of reporter in the reports that name Iodine
ReporterReportsShareShare as a bar
Physician73235.7%
Pharmacist512.5%
Other health professional84341.1%
Lawyer30.1%
Consumer or non-health professional40019.5%
Not given221.1%

Age and sex are as the report gives them. The reporter is the primary source in the report. 58.4% of the reports give the United States as the country.

Reason for use

Reason for use (indication) that the reports of Iodine record
Indication as recorded (MedDRA)ReportsShare
Migraine291.4%
Thyrotoxic crisis221.1%
Computerised tomogram180.9%
Rheumatoid arthritis140.7%
Nutritional supplementation110.5%
Psoriatic arthropathy90.4%

The reporter fills in the indication, and the field is often empty. Each share is of all 2,051 reports.

Drugs in the same reports

Other drugs that the reports of Iodine name, in any role, in order of name
DrugReports that name the two
Acetaminophen454
Actemra217
Adalimumab349
Alendronate sodium229
Celecoxib331
Codeine322
Folic acid222
Methotrexate235
Prednisone243
Tramadol hydrochloride263

The table has the 10 drug names that these reports name most. Two names in one report says only that the report recorded the two. It says nothing about the part of a product in the event.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Pages near this one

These links are for navigation. No count selected them.

Official pages

The site checked these addresses on . The links open in a new tab.

Cite this page

Reported Reactions. Iodine: adverse event reports that FDA received. https://reportedreactions.com/drug/iodine/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of . Reports received through .

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

A report is in the count when it names Iodine as a suspect or interacting product. The 1,572 reports that name it only as a concomitant medicine are not in the count. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

Do these reports show that Iodine was responsible for the reactions?

No. FDA says:

For any given report, there is no certainty that a suspected drug caused the event.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

A reaction can relate to the condition that the drug treats, to other medicines, or to something else.

Is this the list of reactions on the label of Iodine?

No. It is a count of what people reported to FDA: 2,051 reports from February 2004 to June 2026. The FDA-approved label of a product lists its adverse reactions. The official pages at the end of this page link to the labels.

Who sent these reports?

Other health professional (41.1%), physician (35.7%) and consumer or non-health professional (19.5%). These are the types of reporter for the reports that name this drug.

If a manufacturer receives an adverse event report, it is normally required to send the report to FDA.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

How does a person report an adverse event?

FDA runs MedWatch, a program that takes voluntary reports from health professionals, patients and consumers. The guide on how to report has the links.